Optimi Health Corp. is a leading Health Canada licensed psychedelics pharmaceutical manufacturer. The project will utilize KPU-AGC’s state-of-the-art genomics technology. It aims to produce mushrooms rich in psilocybin and other related tryptamine alkaloids. Objectives of the partnership include: DNA mushroom extraction: the AGC will extract DNA from 20 mushrooms.